BIOTEST
DEAD

Serial Number

76374498

Owner

BIOTEST AG

Attorney

John W. McGlynn

First Use Date

Jul 2, 1977

Filing Date

Feb 21, 2002

Add to watchlist:

No watchlists yet
View on USPTO

BIOTEST Trademark

Serial Number: 76374498 • Registration: 2961650

BIOTEST is a trademark filed by BIOTEST AG on February 21, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

BIOTEST AG (32 trademarks)

FRANKFURT/MAIN , DE

Entity Type: 03

Trademark Details

Filing Date

February 21, 2002

Registration Date

June 14, 2005

First Use Anywhere

July 2, 1977

First Use in Commerce

October 5, 1997

Published for Opposition

March 22, 2005

Cancellation Date

January 15, 2016

Goods & Services

[ Plates and multiwell microtiter plates for cell typing, blood and virus diagnostics; blood warmers; apparatus, namely, incubator, cell sorter, cell counter, shaker, pipettes, plates and vials for cell recovery and for handling of cells, including disposable materials; ] measuring and surveying apparatus, namely, [ sample holder, reader, photometer, centrifuge, shaker, incubator, washer, particle counter ] and air sampler for removal, determination and quantification of microorganisms in air, [ liquids ] and on surfaces; [ measuring and surveying kits/systems and agar strips for determination and quantification of substances, namely, blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for sanitary and hygiene monitoring, [ laboratory robot, for automated processing of microtiter plate based assays like ELISAs, DNA hybridization assays and cell agglutination tests; ] kits/systems comprising agar strips, air samplers, [ particle counters, anemometers ] and agar strips for determination of air borne germs and for determination of particle size and number in air; kits/systems comprising air samplers, sample holders and reader for clean room air monitoring; all the foregoing for use in research and/or non-medical laboratories

[ Pharmaceutical and veterinary preparations and products for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; food for babies; medical plasters; materials for wound, burn or surgical dressing; pharmaceutical preparations for hematology, oncology, transplantation medicine, nephrology, pediatrics, for intensive care medicine, namely, blood products, immune globulin preparations, globulin preparations, coagulation factors; medicines for use in transplantation procedures and for influencing blood coagulation; immune globulin preparations for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; serum preparations, and serum proteins and solutions comprising the same for medical use; human albumin for medical use; blood products for medical use, namely, blood plasma; blood substitutes; plasma substitutes and plasma expanders; vaccines, especially on basis of immune globulines; blood coagulation preparations, especially coagulation factors for clinical and medical laboratory use; antibiotics; medicines for treating the central nervous system; medicines for treating heart and circulation diseases; medicines for treating the respiratory system; medicines for urological treatment; medicines for treatment of digestive organs and corresponding/adjoining glands; hormones; vitamins; immunosuppressive, anti-inflammatory, and antiallergic medicines; dermatological, ophtalmological and otological medicines; in-vivo and in-vitro diagnostic preparations for clinical or medical purposes and clinical or medical laboratory use; antibodies, namely, mono- and polyclonal antibodies for use in in-vivo clinical and medical diagnostics and for patient therapy; in vitro diagnostic agents for medical purposes, especially for determination of proteins, such as antibodies, monoclonal antibodies or immune globulins, or for determinations of nucleic acids, for blood group diagnostics and antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, and determination of toxic compounds; test kits comprising ready to use nutrient media for microorganisms, especially bacteria, and reagents for medical and laboratory uses, especially for blood group diagnostics, antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, determination of toxic substances; test kits comprising monoclonal and polyclonal antibodies and natural and recombinant antigenes, for tests on serological and immune genetic basis, and reagents therefore for human and veterinary medical laboratory purposes; immunoassays such as ELISA's, consisting of reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents therefore for human and veterinary medical laboratory purposes; diagnostic preparations for human or veterinary medical uses in the treatment of infections; media for bacteriological cultures, namely, ready-to-use culture media and nutrient media and ingredients thereof ]

[ In-vitro diagnostic preparations for scientific purposes; test kits comprising reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and microtiter plates, and reagents for scientific and research purposes; systems for determining resistance for scientific purposes comprising nutrient media, cell culture media, and dried media; buffers, salts, solvents for research and scientific purposes; test kits comprising buffers, salts, solvents and reagents for industrial and scientific purposes for hygiene monitoring on surfaces, in air and liquids, and systems for identification of germs for scientific and research purposes comprising nutrient media, buffers and salts; DNA probes for tissue typing, germ or pathogen identification and blood group determination ]

[ Medical, apparatus for clinical or diagnostic use, namely, apparatus for serological blood typing, blood grouping or serological detection of blood groups; bottles and containers specially designated for storage and conservation of solutions for transfusions and infusions; transfusion and infusion apparatus and devices, namely, containers, syringes, catheters, transdermal delivery systems comprising blood warmers and plasma for clinical use; apparatus for cell recovery and for handling of cells, including disposable materials, namely, plates, spatula, vials, pipette tips and beakers for clinical or diagnostic use; measuring and surveying apparatus for clinical and diagnostic use, namely, sample holder, reader, photometer, dipsticks, teststrips, and agar strips for determination and quantification of substances, especially blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin; plates and multiwell microtiter plates for cell typing, blood and virus diagnostics for clinical and diagnostic use; all of the foregoing for medical, clinical, diagnostic and/or surgical use ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jan 15, 2016 CAEX
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
Jul 28, 2011 NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 27, 2011 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 27, 2011 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 26, 2011 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jun 14, 2011 815F
TEAS SECTION 8 & 15 RECEIVED
Jun 14, 2011 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 3, 2008 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 3, 2008 COAR
TTAB RELEASE CASE TO TRADEMARKS
Oct 23, 2008 TMBN
CANCELLATION TERMINATED NO. 999999
Oct 23, 2008 CANT
CANCELLATION DENIED NO. 999999
Oct 23, 2008 CAND
CANCELLATION INSTITUTED NO. 999999
Jan 6, 2008 PETC
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2005 R.PR
PUBLISHED FOR OPPOSITION
Mar 22, 2005 PUBO
NOTICE OF PUBLICATION
Mar 2, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 29, 2004 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2004 CNSA
ASSIGNED TO LIE
Aug 27, 2004 ALIE
ASSIGNED TO LIE
Aug 25, 2004 ALIE
EXAMINERS AMENDMENT MAILED
Aug 25, 2004 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 24, 2004 XAEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 7, 2004 CRFA
PAPER RECEIVED
May 7, 2004 MAIL
NON-FINAL ACTION MAILED
Feb 9, 2004 CNRT
CASE FILE IN TICRS
Nov 17, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 20, 2003 CRFA
PAPER RECEIVED
Oct 20, 2003 MAIL
FINAL REFUSAL MAILED
Apr 24, 2003 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2003 CRFA
PAPER RECEIVED
Jan 16, 2003 MAIL
NON-FINAL ACTION MAILED
Jul 18, 2002 CNRT
ASSIGNED TO EXAMINER
Jun 14, 2002 DOCK